FindTrial
Sign In

PET Whole Body Biodistribution Using Florbetapir (18F)

PET Whole Body Biodistribution Using Florbetapir (18F)

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221887
Enrollment
Unknown
Registered
2012-08-13
Start date
2012-08-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese Healthy Volunteers

Interventions

investigational material(s) Generic name etc : florbetapir (18F) (AV-45) INN of investigational material : Therapeutic category code : 43- Radioactive medicines Dosage and Administration for Investig

Sponsors

Eli Lilly Japan K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Japanese cognitively normal healthy males or females at least 45 years of age.

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026